Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP118663.RAZ7EQNRbQ-6mpxHyQhV-__vUITHd0LWsL5NW4rQvWPcY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP118663.RAZ7EQNRbQ-6mpxHyQhV-__vUITHd0LWsL5NW4rQvWPcY130_assertion type Assertion NP118663.RAZ7EQNRbQ-6mpxHyQhV-__vUITHd0LWsL5NW4rQvWPcY130_head.
- NP118663.RAZ7EQNRbQ-6mpxHyQhV-__vUITHd0LWsL5NW4rQvWPcY130_assertion description "[cFLIP represents an attractive therapeutic target for melanoma treatment, especially in combination with TRAIL receptor agonists.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP118663.RAZ7EQNRbQ-6mpxHyQhV-__vUITHd0LWsL5NW4rQvWPcY130_provenance.
- NP118663.RAZ7EQNRbQ-6mpxHyQhV-__vUITHd0LWsL5NW4rQvWPcY130_assertion evidence source_evidence_literature NP118663.RAZ7EQNRbQ-6mpxHyQhV-__vUITHd0LWsL5NW4rQvWPcY130_provenance.
- NP118663.RAZ7EQNRbQ-6mpxHyQhV-__vUITHd0LWsL5NW4rQvWPcY130_assertion SIO_000772 18084329 NP118663.RAZ7EQNRbQ-6mpxHyQhV-__vUITHd0LWsL5NW4rQvWPcY130_provenance.
- NP118663.RAZ7EQNRbQ-6mpxHyQhV-__vUITHd0LWsL5NW4rQvWPcY130_assertion wasDerivedFrom lhgdn-20090331 NP118663.RAZ7EQNRbQ-6mpxHyQhV-__vUITHd0LWsL5NW4rQvWPcY130_provenance.
- NP118663.RAZ7EQNRbQ-6mpxHyQhV-__vUITHd0LWsL5NW4rQvWPcY130_assertion wasGeneratedBy ECO_0000203 NP118663.RAZ7EQNRbQ-6mpxHyQhV-__vUITHd0LWsL5NW4rQvWPcY130_provenance.